06:47:49 Europe / Stockholm

Attachments

Share price & Turnover

Share price change and turnover during the day of this press release

Calendar

2024-12-19 Quarterly Report 2025-Q2
2024-10-12 Ex-date Ordinary Dividend PHI 0.00 SEK
2024-09-16 Quarterly Report 2025-Q1
2024-09-02 Extra General Meeting 2025
2024-06-26 Year-end Report 2024
2024-03-27 Quarterly Report 2024-Q3
2023-12-21 Quarterly Report 2024-Q2
2023-11-15 Extra General Meeting 2024
2023-10-27 Annual General meeting
2023-10-13 Ex-date Ordinary Dividend PHI 0.00 SEK
2023-09-20 Quarterly Report 2024-Q1
2023-06-23 Year-end Report 2023
2023-05-09 Extra General Meeting 2023
2023-03-28 Quarterly Report 2023-Q3
2022-12-21 Quarterly Report 2023-Q2
2022-10-31 Annual General meeting
2022-10-14 Ex-date Ordinary Dividend PHI 0.00 SEK
2022-09-29 Quarterly Report 2023-Q1
2022-06-29 Year-end Report 2022
2022-03-21 Quarterly Report 2022-Q3
2022-03-15 Extra General Meeting 2022
2021-12-29 Quarterly Report 2022-Q2
2021-10-20 Extra General Meeting 2021
2021-10-11 Ex-date Ordinary Dividend PHI 0.00 SEK
2021-09-29 Quarterly Report 2022-Q1
2021-06-24 Year-end Report 2021
2021-03-16 Quarterly Report 2021-Q3
2020-12-14 Quarterly Report 2021-Q2
2020-10-20 Annual General meeting
2020-10-15 Ex-date Ordinary Dividend PHI 0.00 SEK
2020-09-28 Quarterly Report 2021-Q1
2020-06-25 Year-end Report 2020
2020-03-12 Quarterly Report 2020-Q3
2019-12-17 Quarterly Report 2020-Q2
2019-10-16 Ex-date Ordinary Dividend PHI 0.00 SEK
2019-10-15 Annual General meeting
2018-09-27 Ex-date Ordinary Dividend PHI 0.00 SEK
2018-09-26 Annual General meeting
2018-06-18 Extra General Meeting 2019
2018-06-12 Year-end Report 2018
2018-03-12 Quarterly Report 2018-Q3
2017-09-26 Ex-date Ordinary Dividend PHI 0.00 SEK
2017-09-25 Annual General meeting
2017-09-11 Quarterly Report 2018-Q1
2017-06-19 Year-end Report 2017
2017-03-13 Quarterly Report 2017-Q3
2017-01-01 Extra General Meeting 2018
2016-11-30 Quarterly Report 2017-Q2
2016-09-06 Ex-date Ordinary Dividend PHI 0.00 SEK
2016-09-05 Annual General meeting
2016-09-05 Quarterly Report 2017-Q1
2016-06-13 Year-end Report 2016
2016-02-22 Quarterly Report 2016-Q3
2016-02-16 Extra General Meeting 2017
2015-11-30 Quarterly Report 2016-Q2
2015-09-08 Ex-date Ordinary Dividend PHI 0.00 SEK
2015-09-07 Quarterly Report 2016-Q1
2015-09-07 Annual General meeting
2015-06-16 Year-end Report 2015
2015-03-16 Quarterly Report 2015-Q3
2014-12-01 Quarterly Report 2015-Q2
2014-10-07 Ex-date Ordinary Dividend PHI 0.00 SEK
2014-10-06 Annual General meeting
2014-10-06 Quarterly Report 2015-Q1
2014-06-30 Year-end Report 2014

Description

CountrySweden
ListSpotlight
SectorHealth care
IndustryMedical technology
PHI är verksamt inom medicinteknik och utvecklar både hårdvara och mjukvara för kvantitativ analys av levande cellkulturer. Produkterna HoloMonitor® bygger på icke-invasiv QPI-teknologi som insamlar data om cellkvalitet och säljs global via distributörer med fokus på preklinisk cancerforskning, stamcellerforskning och läkemedelsutveckling. Framöver fokuserar PHI på att utveckla sina produkter till den kliniska marknaden och inom regenerativ medicin. PHI har kontor i Lund, Boston, och Winston-Salem.
2024-06-04 09:02:38

Phase Holographic Imaging (PHI) today announces that the Company has terminated the liquidity provider agreement with Pareto Securities AB. The agreement will expire on July 31, 2024. 

PHI assess that the need for a liquidity provider is limited and has therefore terminated the agreement regarding the liquidity provider service with Pareto Securities. The agreement will expire on July 31, 2024.